BSEM: Big Leadership Win Adds Fuel to High-Growth Biotech Story

Discover why BSEM is a high-growth opportunity backed by proven leadership ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. This message is from Huge Alerts. Jason Matuszewski, CEO and Chairman of the Board at BioStem Technologies (OTC: BSEM), has been named a 2025 Florida Award winner by Ernst & Young’s prestigious Entrepreneur of The Year® program  This underlines BSEM’s growing market share and competitive edge in a multibillion-dollar segment of the healthcare market, affirming that the company is a real player in MedTech, not just a speculative story! BioStem Technologies (OTC: BSEM) CEO Jason Matuszewski has been recognized as one of the top entrepreneurial honors in the country by Ernst & Young. The award celebrates Matuszewski’s vision, impact, and exceptional leadership in guiding BioStem to the forefront of regenerative medicine.  Based in Pompano Beach, Florida, BSEM is a trailblazing MedTech company dedicated to healing chronic, non-healing wounds through its proprietary BioREtain® technology. The company’s placental-derived allografts are trusted by clinicians nationwide to meet the rising demand for advanced wound care. With a mission rooted in science, innovation, and patient-first values, BSEM has become a high-growth leader redefining what’s possible in regenerative therapies.  This award win is very good news for BSEM for several reasons, both tangible and strategic. It validates leadership and vision. Being named Entrepreneur of The Year® is one of the most prestigious recognitions in business leadership. It signals that Jason Matuszewski’s leadership is credible, visionary, and results-driven, which boosts investor confidence in BioStem's long-term strategy and execution.  It also puts BSEM in the national spotlight, exposing it to a larger network of potential institutional investors, strategic partners, and analysts. The award acknowledges not just the CEO, but the innovation and success of BioStem’s core technology—BioREtain®—and its effectiveness in addressing chronic wound care. a regional winner, Matuszewski now advances to the national Entrepreneur of The Year® competition this fall, with a chance to represent the U.S. on the global stage in 2026.  BSEM’s revenues skyrocketing, game-changing partnerships, a potential NASDAQ listing, as well as a Zack’s Small Cap Research price target of $35.50, all amplify why the stock should be high on your radar. Discover why BSEM is a high-growth opportunity backed by proven leadership. Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security. We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of BioStem Technologies Inc. (OTC: BSEM) . The compensation consists of up to $2,500 and was received/will be received from Sideways Frequency. This compensation should not be considered as an endorsement of the securities of BioStem Technologies Inc. (OTC: BSEM) and we are not responsible for any errors or omissions in any information provided about the securities of BioStem Technologies Inc. (OTC: BSEM) by Huge Alerts. We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 7/16/2025. Behind the Markets Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices. You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here.   Today's Bonus Content: 3 Dirt-Cheap Stocks You Can’t Afford to Ignore (By clicking this link you agree to receive emails from Trading Tips and our affiliates. You can opt out at any time.)